Immediate Impact
1 from Science/Nature 57 standout
Citing Papers
Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers
2024 Standout
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
2024 Standout
Works of Igor Makhlin being referenced
On the Rise of Cyclin-Dependent Kinase Inhibitors in Breast Cancer: Progress and Ongoing Challenges
2020
Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR -mutant glioblastoma
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Igor Makhlin | 73 | 65 | 47 | 53 | 17 | 227 | |
| Eamonn O’Brien | 127 | 19 | 48 | 47 | 12 | 285 | |
| Andre M. Kallab | 88 | 65 | 8 | 39 | 17 | 278 | |
| Valentin Sotov | 60 | 81 | 26 | 41 | 13 | 232 | |
| Mihai Hârza | 35 | 90 | 59 | 20 | 19 | 188 | |
| Lori Morton | 24 | 87 | 15 | 51 | 15 | 228 | |
| Theresa Czech | 68 | 83 | 38 | 24 | 16 | 267 | |
| Hans Strauß | 83 | 45 | 41 | 17 | 12 | 268 | |
| Jae‐Seung Moon | 34 | 33 | 18 | 60 | 16 | 192 | |
| Seshadri Thirumala | 77 | 72 | 14 | 95 | 21 | 271 | |
| Amy Guppy | 102 | 38 | 36 | 21 | 10 | 293 |
All Works
Login with ORCID to disown or claim papers
Loading papers...